Clinical Trial Assessing Efficacy of Virgin Coconut Oil in Preventing Radiation Mucositis in Patients with Head and Neck Cancer
Phase 4
Completed
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2019/05/019319
- Lead Sponsor
- ATARAJAN KANNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients with Head and Neck Cancers Scheduled to Undergo Radiotherapy, Willing to Participate in the study, Informed Consent
Exclusion Criteria
Patients with Cancers involving sites other than Head and Neck, Patients Not willing to Participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Statistically Significant Effectiveness of Virgin Coconut Oil in Prevention of Radiation Mucositis as Compared to Artificial Saliva in Head and Neck Cancer Patients scheduled to undergo Radiotherapy <br/ ><br> <br/ ><br>2 Statistically Significant Effectiveness of Virgin Coconut Oil in Improving Quality of Life Scores as compared to Artificial Saliva in Head and Neck Cancer Patients scheduled to undergo RadiotherapyTimepoint: END OF EVERY WEEK OF RADIOTHERAPY TILL COMPLETION OF RADIOTHERAPY
- Secondary Outcome Measures
Name Time Method Statistically Significant Effectiveness of Virgin Coconut Oil in Prevention of Radiation Mucositis as Compared to Artificial Saliva in Head and Neck Cancer Patients scheduled to undergo Radiotherapy <br/ ><br> <br/ ><br>2 Statistically Significant Effectiveness of Virgin Coconut Oil in Reducing Salivary Candidal carriage as compared to Artificial Saliva in Head and Neck Cancer Patients scheduled to undergo Radiotherapy <br/ ><br>Timepoint: ASSESSMENT AT END OF EVERY WEEK OF RADIOTHERAPY TILL COMPLETION OF RADIOTHERAPY